1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (215) 662–7804
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896)
A trial of the Eastern Cooperative Oncology Group
Article first published online: 19 AUG 2002
DOI: 10.1002/cncr.10782
Copyright © 2002 American Cancer Society
Additional Information
How to Cite
Vaughn, D. J., Manola, J., Dreicer, R., See, W., Levitt, R. and Wilding, G. (2002), Phase II study of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium and renal dysfunction (E2896). Cancer, 95: 1022–1027. doi: 10.1002/cncr.10782
Publication History
- Issue published online: 19 AUG 2002
- Article first published online: 19 AUG 2002
- Manuscript Accepted: 3 APR 2002
- Manuscript Revised: 13 MAR 2002
- Manuscript Received: 10 JAN 2002
Funded by
- Public Health Service. Grant Numbers: CA23318, CA66636, CA21115, CA15488, CA21076, CA13650
- National Institutes of Health
- Department of Health and Human Services
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1
- 2, , , , Systemic chemotherapy in patients with advanced transitional cell carcinoma of the urothelium and impaired renal function, Anti-Cancer Drugs, 2012, 23, 2, 143
- 3, , , Current treatment of metastatic bladder cancer and future directions, Expert Review of Anticancer Therapy, 2011, 11, 12, 1851
- 4, , , Management of advanced bladder cancer in patients with impaired renal function, Expert Review of Anticancer Therapy, 2011, 11, 6, 931
- 5, , Update on Chemotherapy in the Treatment of Urothelial Carcinoma, The Scientific World Journal, 2011, 11, 1981
- 6, , Vinflunine in the treatment of advanced bladder cancer, Expert Review of Anticancer Therapy, 2011, 11, 1, 13
- 7, , , , , , , , , Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma, Cancer, 2009, 115, 12Direct Link:
- 8, Advanced bladder cancer: So many drugs, so little progress, Cancer, 2008, 113, 6Direct Link:
- 9, Chemotherapeutic options for cisplatin-ineligible patients with advanced carcinoma of the urothelium, Cancer Treatment Reviews, 2008, 34, 4, 328
- 10, , , Current optimal chemotherapy for advanced urothelial cancer, Expert Review of Anticancer Therapy, 2008, 8, 1, 51
- 11, , , , , Neoadjuvant chemotherapy preceding cystectomy for bladder cancer, Expert Opinion on Pharmacotherapy, 2008, 9, 11, 1885
- 12, , , , , Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802), Cancer, 2008, 112, 12Direct Link:
- 13
- 14, , , , Konventionelle und experimentelle Systemtherapie des fortgeschrittenen Urothelkarzinoms, Der Onkologe, 2007, 13, 12, 1109
- 15, , , , , , , Systemic anticancer therapy in gynecological cancer patients with renal dysfunction, International Journal of Gynecological Cancer, 2007, 17, 4Direct Link:
- 16, , The Atypical Urothelial Cancer Patient: Management of Bladder Cancers of Non–Transitional Cell Histology and Cancers of the Ureters and Renal Pelvis, Seminars in Oncology, 2007, 34, 2, 145
- 17, , The evolving role of chemotherapy in advanced urothelial cancer, Current Opinion in Supportive and Palliative Care, 2007, 1, 3, 180
- 18
- 19
- 20, , , , , , , , , Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanoma, Cancer, 2006, 106, 2Direct Link:
- 21
- 22, , Nonplatinum therapy in advanced bladder cancer, Expert Review of Anticancer Therapy, 2006, 6, 6, 887
- 23, , Perioperative chemotherapy for bladder cancer, Critical Reviews in Oncology/Hematology, 2006, 57, 2, 133
- 24, , State-of-the-art management of metastatic disease at initial presentation or recurrence, World Journal of Urology, 2006, 24, 5, 543
- 25, , , Systemic chemotherapy in locally advanced and/or metastatic bladder cancer, Cancer Treatment Reviews, 2006, 32, 6, 456
- 26, , Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials, Current Oncology Reports, 2005, 7, 3, 207
- 27, Neoadjuvant Chemotherapy in Transitional-cell Carcinoma of the Bladder, Clinical Oncology, 2005, 17, 7, 503
- 28, , , , , , , Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium, Cancer, 2005, 103, 11Direct Link:
- 29, , , , , , , , Phase II Trial of Weekly Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Transitional Cell Cancer, European Urology, 2005, 48, 2, 246
- 30
- 31
- 32, , , , , , , Chemotherapy in Locally Advanced and Metastatic Bladder Cancer, European Urology Supplements, 2004, 3, 3, 79
- 33, , , Management of muscle-invasive bladder cancer in the elderly, Expert Review of Anticancer Therapy, 2004, 4, 6, 1017
- 34
- 35
- 36, , Taxus spp.: Botany, Horticulture, and Source of Anti-Cancer Compounds,Direct Link: